Citation Tools

Original research
Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanoma

Download to a citation manager

Cite this article as:
Khushalani NI, Vassallo M, Goldberg JD, et al
Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanoma